Cardiovascular disease test kit BMLPAP0110

COVID-19cholesterollipoprotein

iProtin Assay Cartridge Kit employs SAW Biosensor chips with advanced automated protein coating technology, allowing users to detect a range of biomarkers in the human body within just three minutes. This rapid quantitative data provides doctors with immediate diagnostic insights and supports informed decision-making. Additionally, it enables individuals to monitor their health status effectively. This technology is currently in widespread use across major hospitals, clinics, and by home care physicians. iProtin system enables multiple bio-markers’ tests in one common device. C-reactive protein assay cartridge kit (CE & TFDA approval) Lipoprotein(a) assay cartridge kit (CE, FDA listing & TFDA approval) Apolipoprotein B assay cartridge kit (FDA listing & TFDA approval) Albumin assay cartridge kit (FDA listing & TFDA approval) Microalbumin assay cartridge kit (Coming Soon) Detail of available biomarkers Lp(a) - assessment values emerge as a highly sensitive indicator in the development of coronary artery disease. When evaluating the comprehensive risk of atherosclerosis, Lp(a) measurements should be complemented by assessments of cholesterol, HDL, LDL, and TG. Furthermore, it is recommended to measure Lp(a) values in individuals with dyslipoproteinemia, diabetes mellitus, renal failure, cardiovascular or cerebrovascular disease, and early atherosclerosis. Given that Lp(a) levels are genetically determined and impervious to dietary or lifestyle modifications, screening for diagnosis becomes imperative. Identifying high-risk individuals through screening provides a crucial window for proactive measures to eliminate or manage other risk factors promptly.